SMAD2 and hepatocellular carcinoma: Here we found that (a) TGF-β treatment induced putative cancer stem markers and increased anchorage-independent growth and formation of spheroids in HepG2 cells and (b) knockdown of Smad2 reversed these effects, suggesting that TGF-β signaling played an important role in enhancing the CSCs-like properties in HCC cells.